Introduction
Airway pressure release ventilation (APRV) is a mechanical breathing mode that alternates between two degrees of continuous positive airway pressure (CPAP) support [
1,
2]. It also allows for spontaneous respiratory effort at any CPAP intensity. It is seen as a potentially life-saving method for patients suffering from acute respiratory distress syndrome (ARDS) who are struggling to maintain oxygenation [
3]. APRV is a safe and effective technique for breathing that is pressure-limited, time-triggered, and time-cycled [
1,
2]. The APRV mode employs CPAP with an inverse ratio of inspiration to expiration time (I = E) and can facilitate unrestricted spontaneous breathing in all ventilator cycles to make patients comfortable [
4]. APRV has been found to give lower peak pressure, better oxygenation, less circulatory loss, and better gas exchange than conventional ventilation, without worsening the ARDS patient’s hemodynamic status [
5]. This method is thought to aid in the goal of recruiting consolidated lung regions and preventing recurrent opening and closing of the alveoli (decruitment) [
3]. Research has demonstrated that, when compared to other ventilation modes in ARDS patients, the APRV mode increased gas exchange and arterial oxygenation (PaO
2/FiO
2) ratios [
6,
7]. Previous literature has elucidated that the timely implementation of APRV in adult patients with ARDS is associated with improvements in oxygenation status, respiratory compliance, and a reduction in the duration of both mechanical ventilation and intensive care unit (ICU) stays [
8,
9].
Despite its widespread utilization as an ARDS rescue therapy in many ICUs worldwide, the terminology and settings for the APRV mode may differ slightly, but the concepts remain similar to those of other traditional modes [
2,
10]. APRV settings encompass four fundamental parameters: P-high, T-high, P-low, and T-low. The term P-high denotes the heightened continuous positive airway pressure (CPAP) level sustained for an extended duration (T-high), aiming to facilitate optimal lung volume and alveolar recruitment. Conversely, P-low signifies a brief application of low CPAP pressure during a short period (T-low), wherein the majority of ventilation processes occur [
2,
11]. Established protocols for APRV recommend setting P-high equivalent to the plateau pressure (Pplat) observed during conventional mechanical ventilation (CMV), while maintaining P-low at 0 cm H
2O to prevent alveolar erosion during the release phase. Furthermore, initiating T-high within the range of 4 to 6 s is advised to sustain optimal minute ventilation, with T-low adjusted to achieve the end of expiratory airflow at 75% of the peak expiratory flow rate (PEFR) [
12,
13].
It is not widely known how the APRV mode is utilized in the management of ARDS patients by nurses who work in critical care units, and what barriers there are to using the APRV mode. As a result, we hypothesize that nurses lack proficient knowledge regarding the effective application of APRV to patients diagnosed with ARDS. Thus, the study aimed to assess APRV utilization by nurses who work at critical care units in the management of ARDS patients and identify the most common barriers to not using APRV mode.
Discussion
To the best of our knowledge, there is an extreme paucity of studies examining the clinical practice of APRV among nursing staff who work at critical units in Saudi Arabia. In light of this knowledge gap, this is the first national study to evaluate current awareness, practices, and barriers to the use of APRV mode in ARDS patients among nurses who work at critical units in the Kingdom of Saudi Arabia. Overall, our study’s results indicated that majority of nursing staff did not receive any training in utilizing APRV mode, and neither were they aware of APRV usage in their hospital nor the availability of APRV application guidelines in their facility. In addition, a significant discrepancy was found in nursing responses regarding indication, initial setting, weaning criteria, and discontinuation of APRV placement. However, nurses working in critical units revealed modest consistency in managing APRV settings to mitigate hypoxemia and hypercapnia.
Despite the enormous burden of the implementation of APRV in ARDS patients, APRV placement in the clinical setting remains controversial due to the lack of a standardized protocol [
16,
17]. The clinical effectiveness of APRV mode has not been empirically proven in experimental studies due to the significant heterogeneity in APRV placement settings [
18,
19]. Previous studies have indicated that RTs in Saudi Arabia were not well conversant in the application of APRV, where considerable disparities in setting and managing APRV parameters were observed as a result of a dearth of protocol and training seminars on the effective use of APRV [
20,
21]. In line with this, our study outcomes found that nurses who work in critical units were not well-versed in APRV placement, as the vast majority (75%) had never used APRV mode, and a similar number (77%) had not received training in utilizing APRV mode. Furthermore, over half of the nurses (60%) were unaware of APRV usage in their hospital and two-thirds (66%) were not cognizant of the availability of APRV application guidelines at their facility. Thus, strict adherence to published guidelines, and receiving training in setting and adjusting the fundamental parameters of APRV, are indispensable prerequisites for obtaining the clinical benefit of the APRV application and avoiding life-threatening risks [
12,
13].
Since the emergence of the APRV mode, it has contributed significantly as a rescue strategy for a wide spectrum of diseases, particularly ARDS [
22]. Accordingly, the majority of the nurses in our study (67%) stated that ARDS was a primary indication for APRV application. Previous literature has attested to the clinical benefit of early APRV placement in adult patients with ARDS, as it substantially encourages spontaneous breathing, increases functional residual capacity (FRC), and thus optimizes ventilation/perfusion matching [
2,
23]. A meta-analysis of randomized controlled trials (RCTs) has proven the significant advantages of APRV utilization, as it contributes to lower mortality, shortens the length of stay on a ventilator, and improves lung compliance and oxygenation status [
24]. Notwithstanding, recent evidence has shown that the indication and effectiveness of APRV remain ambiguous due to a lack of robust evidence supporting the purported benefits of APRV [
22,
25].
Understanding the complexity of APRV settings is vitally important for optimal clinical management [
17]. Only one-third of the nurses (32%) reported that the P-high should match up with the plateau pressure (Pplat) on a conventional mechanical ventilator (CMV). These results are consistent with established APRV protocols that suggest setting P-high equal to the measured Pplat in volume control mode or similar to the set inspiratory pressure when switching from pressure control mode [
12,
13]. A survey of 60 healthcare providers revealed that nearly half (48%) were strictly adherent to ARPV protocols for setting P-high [
14]. Moreover, our study observed that approximately 40% of nurses indicated that P-low should be set to the same level as PEEP in a conventional ventilator. This result contradicts the APRV guidelines, which recommend initiating P-low at 0 cm H
2O [
12,
13]. These protocols were closely followed by healthcare professionals in the Miller et al. study, in which three-quarters (78%) set the initial P-value at 0 cm H
2O [
14]. It has previously been observed that setting P-low at 0 cm H
2O generates an intrinsic PEEP that intentionally prevents alveolar erosion during the release phase because it will never permit expiratory flow to terminate below 25% of the peak expiratory flow rate (PEFR) [
11,
26].
Furthermore, the results of our study indicated that almost half (45%) of the nurses thought that T-high should be started between 4 and 6 s, which matches the APRV protocols [
12,
13]. Likewise, 65% of the participants in Miller et al.’s study showed identical findings in the T-high setting [
14]. It is widely recommended that T-high not be set lower than 4 s to provide 8 to 12 releases per minute and consequently maintain optimal minute ventilation [
2]. However, our study findings revealed that around 41% of nurses believed that the T-low should be set between 0.4 and 0.8 s. Similar disparities across healthcare practitioners were seen in Miller et al.’s study, with a significant number (39%) using an arbitrary T-low [
14]. In contrast, several studies have shown the importance of adjusting the T-low to reach the end of expiratory airflow at 75% of the peak expiratory flow rate (PEFR) [
27,
28]. In particular, appropriate adjustment of the T-low plays a pivotal role in stabilizing the alveoli by maintaining sufficient lung volume at the end of expiration to prevent periodic closure and reopening of the pulmonary units at low lung volumes [
29,
30].
Regarding the management of the APRV settings, it was found that more than half of the nursing staff (54%) assumed that the maximum allowed tidal volume (V
t) ranged between 4 and 6 ml/kg. In contrast, healthcare providers in the study by Miller et al. presented erratic results, with most of them (38%) stating that V
t should be set between 6 and 8 ml/kg [
14]. Previous research has pointed out that tidal volume in APRV mode is controlled indirectly by adjusting T-low to maintain V
t between 4 and 6 ml/kg, thus optimizing alveolar ventilation [
2]. Meanwhile, the expiratory time (T-low) should be effectively adjusted to be brief enough to prevent lung recruitment and long enough to attain an adequate tidal volume [
11]. However, it was observed that nearly half (47%) of nurses believed that P-high should be limited to 35 cm H
2O. In accordance with this, healthcare practitioners revealed similar findings in Miller et al.’s study, where 45% of them indicated the same limit [
14]. It is strongly suggested to maintain a P-high less than 35 cm H
2O and below the upper inflection point to reduce trans-alveolar pressure and hence decrease the risk of lung injury [
2,
4,
31].
The results of our survey showed that increasing the P-high was the most dominant technique for enhancing ventilation and oxygenation status. It is well established that prolonged P-high is the first-line intervention in the management of respiratory acidosis and severe hypoxemia. Extended P-high can significantly promote alveolar recruitment by increasing mean airway pressure and lengthening gas exchange, resulting in better oxygenation levels and carbon dioxide clearance [
11,
12]. Additionally, lowering the T-high and raising the T-low can be beneficial in improving alveolar ventilation because they provide greater time for exhalation and removal of PaCO
2 [
13]. Likewise, it has been shown that brief release periods at P-low can significantly improve pulmonary ventilation and lessen life-threatening hypercapnia [
11,
26].
In terms of weaning APRV parameters, our study outcomes revealed that one-third (33%) of nurses believed that weaning of APRV mode should begin with a steady reduction in P-high to achieve 10 cm H
2O, and 44% stated that a gradual increase in T-high should be applied to reach 10 s. These findings are in line with prior APRV protocols that advocated the “drop and stretch” approach to weaning APRV settings, which intended to decrease the P-high by 1 to 2 cm H
2O and increase the T-high by 0.5 s for every 1 cm H
2O drop in P-high [
12,
13]. Furthermore, over half of nursing staff pointed out that an ARDS patient must meet certain criteria before converting to CPAP mode, including FiO
2 ≤ 0.4, a P-high ≤ 10 cm H
2O, and a T-high ≥ 10 s. Accordingly, subsequent studies have revealed the same criteria for switching an ARDS patient to CPAP mode with a PEEP value similar to P-high [
11‐
13].
Although utilizing the APRV mode in patients with APRV has been associated with positive therapeutic outcomes, there are a variety of obstacles that may impede APRV implementation in the clinical setting. Our study analysis found that the most frequently mentioned barriers to adopting APRV mode are an absence of protocols, a heavy workload, and inadequate training. In agreement with this, it has been conclusively shown that the absence of randomized controlled trials is the primary impediment to the use of APRV in patients with ARDS [
17,
18,
32]. A lack of consensus among practitioners in the initiation and management of APRV settings has been noted, which can be attributed to the absence of solid proof supporting the application of APRV placement [
22,
33]. In light of the aforementioned findings, it is highly recommended to establish a training program and implement an institutional policy to improve nursing staff’s knowledge of the effective way to use APRV.
Strengths and limitations
Our study is noteworthy because it is the first of its kind to evaluate Saudi Arabian nurses’ awareness, practice, and barriers related to using the APRV mode with ARDS patients. Additionally, it includes a sizable sample of nursing staff from different geographic areas, which facilitates the generalization of the results throughout the country. Nevertheless, certain limitations may hinder the scope of the research. This is a survey-based study that is unable to pinpoint the root cause of poor awareness of the APRV mode. In light of these limitations, further studies are warranted to examine the mechanism of action and to create evidence-based protocols for APRV mode in an attempt to raise the awareness of nursing staff regarding the optimal application of APRV.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.